tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (AU:CUV)
ASX:CUV
Australian Market
Advertisement

Clinuvel Pharmaceuticals (CUV) Financial Statements

Compare
92 Followers

Clinuvel Pharmaceuticals Financial Overview

Clinuvel Pharmaceuticals 's market cap is currently $636.04M. The company's EPS TTM is AU$0.439; its P/E ratio is 17.54; and it has a dividend yield of 0.40%. Clinuvel Pharmaceuticals is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History

Clinuvel Pharmaceuticals Debt to Assets

Clinuvel Pharmaceuticals Cash Flow

Clinuvel Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis